SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (566)7/23/2001 1:11:35 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 2243
 
Selling 9K of 10K STEM, up about 400%, at the current bid of $6.82.

(from "2000")

Buying a second 1,000 shares of NBIX at current ask of 35 even.

Take photo now, if so inclined.



To: scaram(o)uche who wrote (566)7/24/2001 8:38:59 AM
From: rkrw  Read Replies (1) | Respond to of 2243
 
I'm calling the SEC :-)

biz.yahoo.com

Tuesday July 24, 7:31 am Eastern Time
Press Release
SOURCE: Neurocrine Biosciences
Neurocrine Biosciences and GlaxoSmithKline Announce Worldwide Collaboration For CRF Receptor Antagonists Including the Phase I Compound NBI-34041
Largest Collaboration in Neurocrine's History